Cargando…
Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology
BACKGROUND: The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to lowering thrombogenicity. We report here the in vivo biocompatibility and in vitro hemocompatibility pe...
Autores principales: | Starke, Robert M, Thompson, John, Pagani, Ariana, Choubey, Animesh, Wainwright, John M, Wolf, Michael F, Jahanbekam, Reza, Girdhar, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509525/ https://www.ncbi.nlm.nih.gov/pubmed/32487767 http://dx.doi.org/10.1136/neurintsurg-2020-016043 |
Ejemplares similares
-
Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up
por: Martínez-Galdámez, Mario, et al.
Publicado: (2019) -
Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study
por: Martínez-Galdámez, Mario, et al.
Publicado: (2017) -
Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model
por: Girdhar, Gaurav, et al.
Publicado: (2019) -
Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model
por: Girdhar, Gaurav, et al.
Publicado: (2018) -
Telescoping pipeline vantage embolization devices with shield technology for the treatment of a giant, symptomatic dolichoectatic basilar trunk aneurysm
por: Hackett, Ashia M., et al.
Publicado: (2022)